• 1. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 2. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 3. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267
• 4. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 5. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962

Introduction to (1S)-1-(4-propylphenyl)ethan-1-amine and Its Significance in Modern Chemical Research

(1S)-1-(4-propylphenyl)ethan-1-amine, identified by its CAS number 212968-68-8, is a compound of significant interest in the field of chemical and pharmaceutical research. This molecule, belonging to the amine class, has garnered attention due to its unique structural properties and potential applications in various scientific domains. The precise stereochemistry of this compound, as indicated by the (1S) configuration, plays a crucial role in its interaction with biological systems, making it a valuable subject of study for researchers aiming to develop novel therapeutic agents.

The chemical structure of (1S)-1-(4-propylphenyl)ethan-1-amine consists of a phenyl ring substituted with a propyl group at the para position and an amine functional group attached to the ethyl chain. This arrangement contributes to its distinct physical and chemical properties, which are essential for understanding its behavior in different environments. The presence of the stereocenter at the chiral carbon atom enhances its complexity and makes it a promising candidate for exploring the relationship between molecular structure and biological activity.

In recent years, there has been growing interest in the development of chiral drugs due to their improved efficacy and reduced side effects compared to their racemic counterparts. (1S)-1-(4-propylphenyl)ethan-1-amine exemplifies this trend, as its enantiomeric purity is critical for achieving the desired pharmacological effects. Advanced synthetic methodologies have been employed to produce this compound with high enantiomeric excess, ensuring that its biological activity is maximized while minimizing unwanted interactions.

The pharmaceutical industry has been actively exploring the potential of (1S)-1-(4-propylphenyl)ethan-1-amine in the development of new medications. Its amine group provides a versatile scaffold for further functionalization, allowing chemists to design molecules with specific biological targets. For instance, modifications at the propyl substituent can alter the compound's solubility and metabolic stability, while changes to the phenyl ring can enhance binding affinity to biological receptors. These modifications are essential for optimizing drug candidates for clinical use.

Recent studies have highlighted the role of (1S)-1-(4-propylphenyl)ethan-1-amine in investigating enzyme inhibition and receptor binding mechanisms. Its structural features make it an ideal candidate for studying how small molecules interact with biological targets at the molecular level. By understanding these interactions, researchers can gain insights into disease mechanisms and develop more effective therapeutic strategies. The compound's ability to modulate enzymatic activity has also been explored in the context of metabolic disorders, where precise control over molecular interactions is crucial.

The synthesis of (1S)-1-(4-propylphenyl)ethan-1-amine involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Techniques such as asymmetric synthesis and chiral auxiliary methods have been employed to achieve the desired stereochemical configuration. These synthetic approaches not only highlight the advancements in chemical methodology but also underscore the importance of precision in molecular construction for pharmaceutical applications.

As research continues to evolve, (1S)-1-(4-propylphenyl)ethan-1-amine is expected to play a pivotal role in drug discovery and development. Its unique properties make it a versatile building block for designing novel therapeutics targeting various diseases. The ongoing exploration of its pharmacological potential underscores its significance in modern chemical research and pharmaceutical innovation.

The future prospects of (1S)-1-(4-propylphenyl)ethan-1-amine are promising, with researchers delving deeper into its biological activities and potential therapeutic applications. Collaborative efforts between chemists, biologists, and pharmacologists are essential for unlocking its full potential and translating laboratory findings into clinical benefits. As our understanding of molecular interactions continues to grow, compounds like (1S)-1-(4-propylphenyl)ethan-1-amine will undoubtedly contribute significantly to advancements in medicine.

• 98-84-0(α-Phenylethylamine)
• 586-70-9(1-(4-Methylphenyl)ethylamine)
• 2941-20-0(1-Phenylpropan-1-amine)
• 3082-64-2((R)-(+)-a-Ethylbenzylamine)
• 3886-69-9((1R)-1-phenylethan-1-amine)
• 3789-59-1((S)-(-)-1-Phenylpropylamine)
• 91-00-9(diphenylmethanamine)
• 618-36-0(1-phenylethan-1-amine)
• 138457-19-9((1R)-1-(3-methylphenyl)ethan-1-amine)
• 2627-86-3((S)-alpha-phenylethylamine)